2.8(top 20%)
impact factor
1.9K(top 10%)
papers
60.0K(top 5%)
citations
98(top 5%)
h-index
2.9(top 20%)
impact factor
2.1K
all documents
63.6K
doc citations
135(top 10%)
g-index
Top Articles
# | Title | Journal | Year | Citations |
---|---|---|---|---|
1 | The 2008 WHO classification of lymphomas: implications for clinical practice and translational research | Hematology American Society of Hematology Education Program | 2009 | 481 |
2 | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Hematology American Society of Hematology Education Program | 2011 | 372 |
3 | Hemophagocytic lymphohistiocytosis (HLH) and related disorders | Hematology American Society of Hematology Education Program | 2009 | 296 |
4 | Update on Cobalamin, Folate, and Homocysteine | Hematology American Society of Hematology Education Program | 2003 | 294 |
5 | Recent Advances in Thrombotic Thrombocytopenic Purpura | Hematology American Society of Hematology Education Program | 2004 | 256 |
6 | Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety | Hematology American Society of Hematology Education Program | 2010 | 241 |
7 | Dyskeratosis Congenita | Hematology American Society of Hematology Education Program | 2011 | 236 |
8 | The Role of Platelets in Atherothrombosis | Hematology American Society of Hematology Education Program | 2011 | 225 |
9 | Hemophagocytic lymphohistiocytosis: pathogenesis and treatment | Hematology American Society of Hematology Education Program | 2013 | 222 |
10 | Bacterial Contamination of Blood Components: Risks, Strategies, and Regulation | Hematology American Society of Hematology Education Program | 2003 | 221 |
11 | The Molecular Basis of Leukemia | Hematology American Society of Hematology Education Program | 2004 | 214 |
12 | Drug-induced thrombocytopenia: pathogenesis, evaluation, and management | Hematology American Society of Hematology Education Program | 2009 | 203 |
13 | Evidence-Based Platelet Transfusion Guidelines | Hematology American Society of Hematology Education Program | 2007 | 201 |
14 | FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013? | Hematology American Society of Hematology Education Program | 2013 | 197 |
15 | Pros and cons of new oral anticoagulants | Hematology American Society of Hematology Education Program | 2013 | 193 |
16 | The Hematologist and Radiation Casualties | Hematology American Society of Hematology Education Program | 2003 | 191 |
17 | Recognizing and Managing Chronic Graft-Versus-Host Disease | Hematology American Society of Hematology Education Program | 2008 | 191 |
18 | Acute Myeloid Leukemia | Hematology American Society of Hematology Education Program | 2004 | 189 |
19 | Secondary Iron Overload | Hematology American Society of Hematology Education Program | 2001 | 188 |
20 | Stem Cell Mobilization | Hematology American Society of Hematology Education Program | 2003 | 186 |
21 | FLT3 Mutations: Biology and Treatment | Hematology American Society of Hematology Education Program | 2006 | 185 |
22 | Thalassemia | Hematology American Society of Hematology Education Program | 2004 | 181 |
23 | Diffuse large B-cell lymphoma: R-CHOP failure—what to do? | Hematology American Society of Hematology Education Program | 2016 | 179 |
24 | Deep Venous Thrombosis | Hematology American Society of Hematology Education Program | 2004 | 178 |
25 | T-cell acute lymphoblastic leukemia | Hematology American Society of Hematology Education Program | 2016 | 176 |
26 | Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes | Hematology American Society of Hematology Education Program | 2007 | 174 |
27 | Malaria, erythrocytic infection, and anemia | Hematology American Society of Hematology Education Program | 2009 | 172 |
28 | Drug-induced immune hemolytic anemia | Hematology American Society of Hematology Education Program | 2009 | 171 |
29 | Hepcidin and Its Role in Regulating Systemic Iron Metabolism | Hematology American Society of Hematology Education Program | 2006 | 169 |
30 | The role of NOTCH1 signaling in T-ALL | Hematology American Society of Hematology Education Program | 2009 | 167 |
31 | Iron overload in thalassemia: different organs at different rates | Hematology American Society of Hematology Education Program | 2017 | 167 |
32 | Hypercoagulability in Sickle Cell Disease: New Approaches to an Old Problem | Hematology American Society of Hematology Education Program | 2007 | 166 |
33 | Current concepts in the pathophysiology and treatment of aplastic anemia | Hematology American Society of Hematology Education Program | 2013 | 165 |
34 | Approach to Hemophagocytic Syndromes | Hematology American Society of Hematology Education Program | 2011 | 159 |
35 | Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia | Hematology American Society of Hematology Education Program | 2016 | 158 |
36 | Familial and Acquired Hemophagocytic Lymphohistiocytosis | Hematology American Society of Hematology Education Program | 2005 | 156 |
37 | The molecular genetic makeup of acute lymphoblastic leukemia | Hematology American Society of Hematology Education Program | 2012 | 156 |
38 | Atypical Cellular Disorders | Hematology American Society of Hematology Education Program | 2004 | 154 |
39 | Stem Cells: Hype and Reality | Hematology American Society of Hematology Education Program | 2002 | 153 |
40 | Iron Deficiency and Overload | Hematology American Society of Hematology Education Program | 2003 | 153 |
41 | Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance | Hematology American Society of Hematology Education Program | 2009 | 153 |
42 | Minimal Residual Disease in Acute Lymphoblastic Leukemia | Hematology American Society of Hematology Education Program | 2010 | 152 |
43 | Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia | Hematology American Society of Hematology Education Program | 2011 | 152 |
44 | Dendrimer-based nanoparticles for cancer therapy | Hematology American Society of Hematology Education Program | 2009 | 151 |
45 | The post-thrombotic syndrome | Hematology American Society of Hematology Education Program | 2016 | 151 |
46 | How to approach thrombocytopenia | Hematology American Society of Hematology Education Program | 2012 | 150 |
47 | Venous Thrombosis: The Role of Genes, Environment, and Behavior | Hematology American Society of Hematology Education Program | 2005 | 148 |
48 | Independent prognostic factors for AML outcome | Hematology American Society of Hematology Education Program | 2009 | 147 |
49 | Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia | Hematology American Society of Hematology Education Program | 2008 | 146 |
50 | Chronic Myelogenous Leukemia | Hematology American Society of Hematology Education Program | 2002 | 141 |